PHA 543613

CAS No. 478149-53-0

PHA 543613( —— )

Catalog No. M33906 CAS No. 478149-53-0

PHA 543613 is a specific agonist of α7 nAChR (Ki = 8.8 nM) and can be used in studies about the cognitive deficits of Alzheimer's disease and schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 70 Get Quote
5MG 104 Get Quote
10MG 169 Get Quote
25MG 365 Get Quote
50MG 624 Get Quote
100MG 896 Get Quote
500MG 1944 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PHA 543613
  • Note
    Research use only, not for human use.
  • Brief Description
    PHA 543613 is a specific agonist of α7 nAChR (Ki = 8.8 nM) and can be used in studies about the cognitive deficits of Alzheimer's disease and schizophrenia.
  • Description
    PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors. PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male CD-1 mice with (intracerebral hemorrhage) ICH-induction or sham surgeryDosage:4 and 12 mg/kg Administration:Intraperitoneal injection; 4 and 12 mg/kg; 1 hour after surgery Result:Increased p-Akt and decreased p-GSK-3 and CC3 expressions in the ipsilateral hemisphere and reduced the neuronal cell death in the perihematomal area. Attenuated behavioral deficits and brain edema at 72 hours after ICH.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    478149-53-0
  • Formula Weight
    271.31
  • Molecular Formula
    C15H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (921.46 mM; Ultrasonic )H2O : 100 mg/mL (368.58 mM; Ultrasonic)
  • SMILES
    O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Donn G Wishka, et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. J Med Chem. 2006 Jul 13;49(14):4425-36. ?
molnova catalog
related products
  • SSR 180

    SSR 180 is a potent and subtype-selective α7 agonist with applications in the study of Alzheimer;s disease and schizophrenia.

  • Pozanicline dihydroc...

    Pozanicline dihydrochloride is an orally bioavailable agonist of nicotinic acetylcholine receptor (nAChR) (Ki = 16.7 nM).

  • ASM-024

    ASM-024, a potent nicotinic receptor agonist, is a small molecule synthetic piperazine compound that promotes different targets and signaling pathways of β2-adrenergic receptors mediating smooth muscle relaxation.